loadpatents
name:-0.053462982177734
name:-0.026516914367676
name:-0.011538982391357
GOLETZ; Steffen Patent Filings

GOLETZ; Steffen

Patent Applications and Registrations

Patent applications and USPTO patent grants for GOLETZ; Steffen.The latest application filed is for "fusion protein constructs comprising an anti-muc1 antibody and il-15".

Company Profile
13.41.56
  • GOLETZ; Steffen - Berlin DE
  • GOLETZ; Steffen - Glienicke-Nordbahn DE
  • Goletz; Steffen - Glienicke DE
  • Goletz; Steffen - Glienickke-Nordbahn N/A DE
  • Goletz; Steffen - Glienicke-Nosbahn N/A DE
  • Goletz, Steffen - Glienicke-Nosdbahn DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Fusion Protein Constructs Comprising an Anti-MUC1 Antibody and IL-15
App 20210107961 - GELLERT; Johanna ;   et al.
2021-04-15
Pd-l1 And Ta-muc1 Antibodies
App 20200148785 - Kehler; Patrik ;   et al.
2020-05-14
Multispecific Antibody Constructs Binding To Muc1 And Cd3
App 20200131275 - GOLETZ; Steffen ;   et al.
2020-04-30
Humanized Anti-cd40 Antibodies
App 20200087410 - GOLETZ; Steffen ;   et al.
2020-03-19
Use Of Human Cells Of Myeloid Leukaemia Origin For Expression Of Antibodies
App 20190359731 - GOLETZ; Steffen ;   et al.
2019-11-28
Anti-cancer Treatments With An Anti-muc1 Antibody And An Erbb Inhibitor
App 20190343953 - GOLETZ; Steffen ;   et al.
2019-11-14
Natural Microorganisms Which Are Naturally Capable Of Binding Toxins And/or Toxin Receptors
App 20190257832 - ULSEMER; Philippe ;   et al.
2019-08-22
Means And Methods For Modifying Multiple Alleles
App 20190185848 - Nawrath; Karina ;   et al.
2019-06-20
Use of human cells of myeloid leukemia origin for expression of antibodies
Grant 10,280,230 - Goletz , et al.
2019-05-07
Eukaryotic expression vectors comprising regulatory elements of the globin gene clusters
Grant 10,184,135 - Goletz , et al. Ja
2019-01-22
Mammalian Follicle-stimulating Hormone Composition With Increased Stability
App 20180264086 - Goletz; Steffen ;   et al.
2018-09-20
Method for Detecting Nucleic Acids in Samples Containing Biological Material
App 20180230552 - Goletz; Steffen ;   et al.
2018-08-16
Heteromers Comprising Antibody Domain Fusion Proteins
App 20180216093 - GOLETZ; Steffen ;   et al.
2018-08-02
Small Scale Cultivation Method For Suspension Cells
App 20180135091 - GOLETZ; Steffen ;   et al.
2018-05-17
Eukaryotic Expression Vectors Comprising Regulatory Elements Of The Globin Gene Clusters
App 20180094279 - GOLETZ; Steffen ;   et al.
2018-04-05
Glycooptimized Antibody Drug Conjugates
App 20180028680 - HART; Felix ;   et al.
2018-02-01
Recognition molecules for the treatment and detection of tumors
Grant 9,845,361 - Goletz , et al. December 19, 2
2017-12-19
Microorganisms carrying a tumor antigen
Grant 9,700,610 - Goletz , et al. July 11, 2
2017-07-11
Controlled Ovarian Hyperstimulation With Improved Recombinant Human Follicle-stimulating Hormone
App 20170035854 - GOLETZ; Steffen ;   et al.
2017-02-09
Recombinant human follicle-stimulating hormone
Grant 9,527,899 - Goletz , et al. December 27, 2
2016-12-27
Microorganisms or fractions thereof capable of activating cellular immunity against carbohydrates
Grant 9,494,587 - Goletz , et al. November 15, 2
2016-11-15
Method for the production of an immunostimulating mucin (MUC1)
Grant 9,487,567 - Goletz , et al. November 8, 2
2016-11-08
Glycosylated Glycophorin Peptides
App 20160304577 - GOLETZ; Steffen ;   et al.
2016-10-20
Fab-glycosylated antibodies
Grant 9,359,439 - Goletz , et al. June 7, 2
2016-06-07
Tumor-specific recognition molecules
Grant 9,345,794 - Goletz , et al. May 24, 2
2016-05-24
Anti-cancer Treatments With Anti-egfr Antibodies Having A Low Fucosylation
App 20160068609 - GOLETZ; Steffen ;   et al.
2016-03-10
Use Of Human Cells Of Myeloid Leukaemia Origin For Expression Of Antibodies
App 20150368363 - GOLETZ; Steffen ;   et al.
2015-12-24
MUC1 antibodies
Grant 9,217,038 - Goletz , et al. December 22, 2
2015-12-22
Peptides For Enhancing Protein Expression
App 20150353959 - GOLETZ; Steffen ;   et al.
2015-12-10
Novel Therapeutic Treatments With Anti-her2 Antibodies Having A Low Fucosylation
App 20150166664 - Goletz; Steffen ;   et al.
2015-06-18
Humanized EGFR antibodies
Grant 9,051,370 - Goletz , et al. June 9, 2
2015-06-09
Use of human cells of myeloid leukaemia origin for expression of antibodies
Grant 9,051,356 - Goletz , et al. June 9, 2
2015-06-09
MUTZ-3 dendritic cells
Grant 9,029,143 - Goletz , et al. May 12, 2
2015-05-12
Microorganisms Of The Species Bacteroides Xylanisolvens
App 20150118354 - Goletz; Steffen ;   et al.
2015-04-30
Method For The Production Of An Immunostimulating Mucin (muc1)
App 20150010495 - Goletz; Steffen ;   et al.
2015-01-08
Recognition Molecules For The Treatment And Detection Of Tumors
App 20150005474 - Goletz; Steffen ;   et al.
2015-01-01
Microorganisms Carrying A Tumor Antigen
App 20140302093 - Goletz; Steffen ;   et al.
2014-10-09
Process for the purification of glycoproteins
Grant 8,846,344 - Goletz , et al. September 30, 2
2014-09-30
Recognition molecules for the treatment and detection of tumors
Grant 8,779,102 - Goletz , et al. July 15, 2
2014-07-15
Fermentation process
Grant 8,741,365 - Goletz , et al. June 3, 2
2014-06-03
Tumor-specific Recognition Molecules
App 20140099259 - Goletz; Steffen ;   et al.
2014-04-10
Method for the production of an immunostimulating mucin (MUC1)
Grant 8,642,276 - Goletz , et al. February 4, 2
2014-02-04
Tumor-specific recognition molecules
Grant 8,617,846 - Goletz , et al. December 31, 2
2013-12-31
Highly active glycoproteins-process conditions and an efficient method for their production
Grant 8,609,370 - Goletz , et al. December 17, 2
2013-12-17
Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof
Grant 8,592,165 - Goletz , et al. November 26, 2
2013-11-26
Humanized Egfr Antibodies
App 20130273033 - Goletz; Steffen ;   et al.
2013-10-17
Fab-glycosylated Antibodies
App 20130209458 - Goletz; Steffen ;   et al.
2013-08-15
Differentiation of MUTZ-3 cells to produce effective dendritic cells
Grant 8,455,253 - Goletz , et al. June 4, 2
2013-06-04
Recombinant Human Follicle-stimulating Hormone
App 20130137636 - Goletz; Steffen ;   et al.
2013-05-30
Process For The Purification Of Glycoproteins
App 20120329092 - Goletz; Steffen ;   et al.
2012-12-27
Production And Use Of Human Cd124- And Cd-116-positive Tumor Cell Lines In The Production Of Allogenic Or Semi-allogenic Immunotherapy Agents
App 20120308607 - Goletz; Steffen ;   et al.
2012-12-06
Cancer Stem Cell Markers And Uses Thereof
App 20120294859 - Goletz; Steffen ;   et al.
2012-11-22
Tumour cell lines and uses thereof
Grant 8,283,161 - Goletz , et al. October 9, 2
2012-10-09
Process For The Purification Of Glycoproteins
App 20120252069 - Goletz; Steffen ;   et al.
2012-10-04
Tumor-specific Recognition Molecules
App 20120149877 - Goletz; Steffen ;   et al.
2012-06-14
Muc1 Antibodies
App 20120128676 - Goletz; Steffen ;   et al.
2012-05-24
Perfusion Bioreactor
App 20120100576 - Goletz; Steffen ;   et al.
2012-04-26
Tumor-specific recognition molecules
Grant 8,088,357 - Goletz , et al. January 3, 2
2012-01-03
Tumour Cell Lines and Uses Thereof
App 20110319590 - Goletz; Steffen ;   et al.
2011-12-29
Tumour cell lines and uses thereof
Grant 8,017,388 - Goletz , et al. September 13, 2
2011-09-13
Fermentation Process
App 20110129570 - Goletz; Steffen
2011-06-02
Carbohydrate Specific Cellular Immunity Inducing Microorganisms And Fractions Thereof
App 20100303837 - Goletz; Steffen ;   et al.
2010-12-02
Method For The Production Of An Immunostimulating Mucin (muc1)
App 20100273992 - GOLETZ; Steffen ;   et al.
2010-10-28
Microorganisms Or Fractions Thereof Capable Of Activating Cellular Immunity Against Carbohydrates
App 20100158952 - Goletz; Steffen
2010-06-24
Use Of Human Cells Of Myeloid Leukaemia Origin For Expression Of Antibodies
App 20100028947 - Goletz; Steffen ;   et al.
2010-02-04
Process for the production of temperature-induced tumor cell lysates for use as immunogenic compounds
Grant 7,595,192 - Goletz , et al. September 29, 2
2009-09-29
Highly Active Glycoproteins-Process Conditions and an Efficient Method for their Production
App 20080226681 - Goletz; Steffen ;   et al.
2008-09-18
Method for the production of an immunostimulating mucin (muc1)
App 20070116704 - Goletz; Steffen ;   et al.
2007-05-24
Tumour cell lines nm-f9 (dsm acc2606) and nm-d4 (dsm acc2605), uses thereof
App 20060292129 - Goletz; Steffen ;   et al.
2006-12-28
Recognition molecules for the treatment and detection of tumours
App 20060292643 - Goletz; Steffen ;   et al.
2006-12-28
Tumor-specific recognition molecules
App 20060251668 - Goletz; Steffen ;   et al.
2006-11-09
Process for the production of temperature-induced tumor cell lysates for use as immunogenic compounds
App 20060127419 - Goletz; Steffen ;   et al.
2006-06-15
Production and use of human cd124 and cd 116 positive tumour cell lines in the production of allogenic or semi-allogenic immunotherapy agents
App 20040265998 - Goletz, Steffen ;   et al.
2004-12-30
Method for the isolation of large variances of specific molecules for a target molecule from phagemid gene libraries, and a test kit
App 20040214242 - Goletz, Steffen ;   et al.
2004-10-28
Use of selectin-binding pregnancy proteins, liposomes, native mucin fragments and mimetic compounds for the treatment and prophylaxis inflammatory diseases, for preventing metastatic spread and for the prophylaxis of tumour diseases
App 20040191303 - Stahn, Renate ;   et al.
2004-09-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed